Aging

HIGHLIGHTS

• who: Weiqi Meng and colleagues from the Department of Clinical Pharmacy, The First Hospital of Jilin University, Jilin University, Changchun, Jilin, PRChina have published the research work: AGING, in the Journal: (JOURNAL)
• what: This study provides the experimental basis for the application of ZQFZ as a therapeutic agent for CRC. The authors propose that ZQFZ may be used as both an immunomodulator and an anti-myelosuppressive agent . In this study, the anti-CRC effects of ZQFZ were demonstrated in RAW264.7 cells and B6/JGptApcem1Cin(MinC)/Gpt (ApcMin/+) mice. The contribution of NK cells to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.